Anti-Inflammatory Drugs Market is expected to reach US$ 198.92 billion by 2031 | Top key players - AbbVie Inc., Johnson & Johnson Services, Inc., Pfizer Inc.

Market Size and Growth:

The Global Anti-inflammatory Drugs Market size reached US$ 102.72 billion in 2023 and is expected to reach US$ 198.92 billion by 2031, growing at a CAGR of 8.7% during the forecast period 2024-2031.

Anti-Inflammatory Drugs Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/anti-inflammatory-drugs-market?sz

The Anti-Inflammatory Drugs Market refers to the global industry focused on the development, production, and distribution of medications that reduce inflammation, pain, and swelling caused by conditions such as arthritis, autoimmune disorders, and injuries. It includes nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and biologics, addressing rising healthcare demands for effective treatments across diverse patient populations.

Recent Key Developments USA and Japan:

USA:

August 29, 2025: The FDA approved Wayrilz (rilzabrutinib) to treat chronic immune thrombocytopenia.

July 23, 2025: The FDA approved Anzupgo (delgocitinib) for moderate-to-severe chronic hand eczema.

Japan:

August 5, 2025: Kyoto University announced the discovery of a new non-opioid painkiller, ADRIANA, with clinical development underway.

March 27, 2025: Janssen Pharmaceutical K.K. received approval for Tremfya (guselkumab) for the remission and maintenance therapy of moderate to severe ulcerative colitis.

Market Key Players:

AbbVie Inc.
Johnson & Johnson Services, Inc.
Pfizer Inc.
F. Hoffmann-La Roche Ltd
AstraZeneca
Novartis AG
Amgen Inc.
GSK plc
Merck & Co., Inc.
Bristol-Myers Squibb Company
Viatris Inc.

Growth Forecast Projected:

The Global Anti-Inflammatory Drugs Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Anti-Inflammatory Drugs Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=anti-inflammatory-drugs-market

Market Segmentation:

By Drug Class: Anti-Inflammatory Biologics, Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids, Immune Selective Anti-Inflammatory Derivatives (ImSAIDs), Others.

By Application: Arthritis, Chronic Obstructive Pulmonary Disease (COPD), Multiple Sclerosis, Inflammatory Bowel Disease (IBD), Asthma, Tendonitis, Others.

By Route of Administration: Oral, Injection, Inhalation, Topical.

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/anti-inflammatory-drugs-market

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

➠ How big is the Anti-Inflammatory Drugs market?

➠ Who are the key players in the Anti-Inflammatory Drugs market?

➠ What is the projected growth rate of the Anti-Inflammatory Drugs market?

➠ What is the market forecast for the Anti-Inflammatory Drugs industry by 2033?

➠ Which region is estimated to dominate the Anti-Inflammatory Drugs market through the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.